Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: Diagnostic value and correlation with disease phenotype

American Journal of Gastroenterology

Volumn 99, Issue 11, 2004, Pages 2235-2241

  Zholudev, Anna ^b   Zurakowski, David ^b   Young, Wes ^b   Leichtner, Alan ^b   Bousvaros, Athos ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; OUTER MEMBRANE PROTEIN C;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHILD; COLON RESECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DESCENDING COLON; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; ILEUM; ILEUM RESECTION; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SERUM; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADOLESCENT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, BACTERIAL; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; ESCHERICHIA COLI; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; PORINS; PREDICTIVE VALUE OF TESTS; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY;

EID: 8744262944     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40369.x     Document Type: Article

References (26)

1. Duerr R, Targan S, Landers C, et al. Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991;100:1385-91.
2. Duerr R, Targan S, Landers C, et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991;100:1590-6.
3. Halbwachs-Mecarelli L, Nusbaum P, Noel L, et al. Anti-neutrophil cytoplasmic antibodies directed against cathepsin G in ulcerative colitis, Crohn's disease, and primary sclerosing cholangitis. Clin Exp Immunol 1992;90:79-84.
4. Billing P, Tahir S, Calfin B, et al. Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am J Pathol 1995;147:979-87.
5. Sendid B, Colombel J, Jacquinot P, et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 1996;3:219-26.
6. Proujansky R, Fawcett P, Gibney K, et al. Examination of anti-neutrophil cytoplasmic antibodies in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1993;17:193-7.
7. Winter H, Landers C, Winkelstein A, et al. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis. J Pediatr 1994;125:707-11.
8. Ruemmele F, Targan S, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115:822-9.
9. Hoffenberg E, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr 1999;134:447-52.
10. Dubinsky M, Offman J, Urman M, et al. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001;96:758-65.
11. Hyams J, Ferry G, Mandel F, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
12. Kozarek R, Patterson D, Gelfand M, et al. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989;110:353-6.
13. Landers C, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto and microbial antigens. Gastroenterology 2002;123:689-99.
14. Eggena M, Cohavy O, Parseghian M, et al. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J Autoimmun 2000;14:83-97.
15. Armitage P, Berry G, Matthews J. Statistical methods in medical research, 4th Ed. Oxford, UK: Blackwell Publishing, 2002:277-82.
16. Hosmer D, Lemeshow S. Applied logistic regression, 2nd Ed. New York: John Wiley and Sons, 2000:47-69.
17. Hunink M, Glasziou P, Siegel J, et al. Interpreting diagnostic information. In Decision making in health and medicine: Integrating evidence and values. Cambridge, UK: Cambridge University, 2001:128-56.
18. Vasiliauskas E, Kam L, Karp L, et al. Marker antibody expression stratifies Crohn's disease into immunologically homogenous subgroups with distinct clinical characteristics. Gut 2000;47:487-96.
19. Koutroubakis I, Petinaki E, Mouzas I, et al. Anti-Saccharomyces cerevisiae mannan antibodies and anti-neutrophil cytoplasmic antibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol 2001;96:449-54.
20. Vermeire S, Joossens S, Peeters M, et al. Comparative study of ASCA assays in inflammatory bowel disease. Gastroenterology 2001;120:827-33.
21. Quinton J, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788-91.
22. Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of Anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol 2001;96:730-4.
23. Esters N, Joossens S, Noman M, et al. Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease. Am J Gastroenterol 2002;97:1458-62.
24. Sutton C, Yang H, Li Z, et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000;46:58-63.
25. Sendid B, Quinton J, Charrier G, et al. Anti-Saccharomyces cerevisiae manna antibodies in familial Crohn's disease. Am J Gastroenterol 1998;93:1306-10.
26. Annese V, Andreoli A, D'Inca R, et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: A GISC study. Am J Gastroenterol 2001;96:2407-12.